Loading...
Prognostic markers and trials in penile cancer
Naushad, Naufal Deb, AA Agag, AA Serag, HA Sangar, Vijay K
Naushad, Naufal
Deb, AA
Agag, AA
Serag, HA
Sangar, Vijay K
Citations
Altmetric:
Abstract
New tumor biomarkers open the potential for designing personalized therapy for penile squamous cell carcinoma. Despite the initial promising results of some biomarkers, controversy remains due to contradictory studies. Further robust research work is required before incorporating biomarkers in the personalized management of penile cancer. This narrative review aims to highlight some of the most commonly and recently investigated biomarkers of penile cancer and to summarize the ongoing registered clinical trials for the management of penile cancer patients.
Description
Date
2023
Publisher
Collections
Files
Keywords
Type
Article
Citation
Naushad N, Deb AA, Agag AA, Serag HA, Sangar VK. Prognostic Markers and Trials in Penile Cancer. Urology research & practice. 2023 May;49(3):138-46. PubMed PMID: 37877863. Pubmed Central PMCID: PMC10346112. Epub 2023/10/25. eng.